Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Literature DB >> 23703457

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Michael Souvatzoglou¹, Matthias Eiber, Axel Martinez-Moeller, Sebastian Fürst, Konstantin Holzapfel, Tobias Maurer, Sibylle Ziegler, Stephan Nekolla, Markus Schwaiger, Ambros J Beer.

Abstract

PET/MR is a new multimodal imaging technique that is expected to improve diagnostic performance of imaging in conditions in which assessment of changes in soft tissue is important such as prostate cancer. Despite substantial changes in PET technology compared to PET/CT, initial studies have demonstrated that integrated PET/MR provides comparable image quality to that of PET/CT, retaining PET quantification efficacy. In this review we briefly describe technological changes compared to PET/CT that made integrated PET/MR possible, propose acquisition protocols for evaluation of prostate cancer with this new multimodal approach, present initial results concerning the application of PET/MR in prostate cancer, and outline the potential for further clinical applications, focusing on potential incremental value compared to present diagnostic performance.

Entities: Disease

Mesh：

Year: 2013 PMID： 23703457 DOI： 10.1007/s00259-013-2445-4

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

47 in total

Review 1. Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors: Gerald Antoch; Andreas Bockisch
Journal: Eur J Nucl Med Mol Imaging Date: 2009-03 Impact factor: 9.236

2. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors: Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal: Eur Radiol Date: 2008-09-30 Impact factor: 5.315

3. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects.

Authors: Hisanobu Koyama; Yoshiharu Ohno; Atsushi Kono; Daisuke Takenaka; Yoshimasa Maniwa; Yoshihiro Nishimura; Chiho Ohbayashi; Kazuro Sugimura
Journal: Eur Radiol Date: 2008-05-06 Impact factor: 5.315

4. Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.

Authors: Ivan Jambor; Ronald Borra; Jukka Kemppainen; Virva Lepomäki; Riitta Parkkola; Kirsti Dean; Kalle Alanen; Eveliina Arponen; Martti Nurmi; Hannu J Aronen; Heikki Minn
Journal: Eur J Radiol Date: 2012-02-18 Impact factor: 3.528

Review 5. Radiologic diagnosis of bone metastases.

Authors: D I Rosenthal
Journal: Cancer Date: 1997-10-15 Impact factor: 6.860

Review 6. Radiological imaging for the diagnosis of bone metastases.

Authors: L D Rybak; D I Rosenthal
Journal: Q J Nucl Med Date: 2001-03

7. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors: Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal: J Nucl Med Date: 2011-11-11 Impact factor: 10.057

Review 8. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors: Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal: J Magn Reson Imaging Date: 2010-12 Impact factor: 4.813

9. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162

Review 10. An integrated MR/PET system: prospective applications.

Authors: Heinz-Peter Schlemmer; Bernd J Pichler; Robert Krieg; Wolf-Dieter Heiss
Journal: Abdom Imaging Date: 2009-11

17 in total

Review 1. Current use of PSMA-PET in prostate cancer management.

Authors: Tobias Maurer; Matthias Eiber; Markus Schwaiger; Jürgen E Gschwend
Journal: Nat Rev Urol Date: 2016-02-23 Impact factor: 14.432

2. A novel alternative to classify tissues from T 1 and T 2 relaxation times for prostate MRI.

Authors: Jorge Zavala Bojorquez; Stéphanie Bricq; François Brunotte; Paul M Walker; Alain Lalande
Journal: MAGMA Date: 2016-05-09 Impact factor: 2.310

Review 3. Imaging biomarkers in prostate cancer: role of PET/CT and MRI.

Authors: M Picchio; P Mapelli; V Panebianco; P Castellucci; E Incerti; A Briganti; G Gandaglia; M Kirienko; F Barchetti; C Nanni; F Montorsi; L Gianolli; S Fanti
Journal: Eur J Nucl Med Mol Imaging Date: 2015-01-17 Impact factor: 9.236

Review 4. Positron emission tomography-magnetic resonance imaging: technical review.

Authors: Raymond F Muzic; Frank P DiFilippo
Journal: Semin Roentgenol Date: 2014-10-18 Impact factor: 0.800

5. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.

Authors: Christian H Pfob; Sibylle Ziegler; Frank Philipp Graner; Markus Köhner; Sylvia Schachoff; Birgit Blechert; Hans-Jürgen Wester; Klemens Scheidhauer; Markus Schwaiger; Tobias Maurer; Matthias Eiber
Journal: Eur J Nucl Med Mol Imaging Date: 2016-05-20 Impact factor: 9.236

6. First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.

Authors: Franz Buchegger; Valentina Garibotto; Thomas Zilli; Laurent Allainmat; Sandra Jorcano; Hansjörg Vees; Olivier Rager; Charles Steiner; Habib Zaidi; Yann Seimbille; Osman Ratib; Raymond Miralbell
Journal: Eur J Nucl Med Mol Imaging Date: 2013-10-09 Impact factor: 9.236